Contact
Please use this form to send email to PR contact of this press release:
Applied Therapeutics Announces FDA Orphan Drug Designation for AT-007 in Galactosemia
TO:
Please use this form to send email to PR contact of this press release:
Applied Therapeutics Announces FDA Orphan Drug Designation for AT-007 in Galactosemia
TO: